Certara Inc (CERT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Certara Inc (CERT) has a cash flow conversion efficiency ratio of 0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($28.82 Million) by net assets ($1.06 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Certara Inc market cap and net worth for the company's overall valuation and market capitalisation.
Certara Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Certara Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Certara Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Certara Inc ranked by their cash flow conversion efficiency. Explore CERT cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hefei Urban Construction Development Co Ltd
SHE:002208
|
-0.260x |
|
Rategain Travel Technologies Limited
NSE:RATEGAIN
|
0.025x |
|
Shanghai Datun Energy Resources Co Ltd
SHG:600508
|
0.021x |
|
Giant Manufacturing Co Ltd
TW:9921
|
0.111x |
|
Invisio Communications AB
ST:IVSO
|
0.047x |
|
Acbel Polytech Inc
TW:6282
|
0.013x |
|
Zhongnongfa Seed Industry Group Co Ltd
SHG:600313
|
-0.021x |
|
Suzhou Hycan Holdings Co Ltd
SHE:002787
|
0.089x |
Annual Cash Flow Conversion Efficiency for Certara Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Certara Inc from 2018 to 2025. View Certara Inc (CERT) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.06 Billion | $96.33 Million | 0.091x | +19.24% |
| 2024-12-31 | $1.06 Billion | $80.47 Million | 0.076x | -3.85% |
| 2023-12-31 | $1.05 Billion | $82.75 Million | 0.079x | -7.77% |
| 2022-12-31 | $1.08 Billion | $92.54 Million | 0.086x | +47.88% |
| 2021-12-31 | $1.04 Billion | $60.39 Million | 0.058x | +6.34% |
| 2020-12-31 | $822.13 Million | $44.81 Million | 0.055x | -29.47% |
| 2019-12-31 | $492.05 Million | $38.02 Million | 0.077x | +228.51% |
| 2018-12-31 | $492.77 Million | $11.59 Million | 0.024x | -- |
About Certara Inc
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pha… Read more